Euroapi S.A. (EAPI.PA)
EUR 2.8
(-0.85%)
EUR 2.8
(-0.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -155.39 Million EUR | -35.85% |
| 2022 | 71.2 Million EUR | 69.99% |
| 2021 | 62.4 Million EUR | 58.3% |
| 2020 | 61.6 Million EUR | -15.14% |
| 2019 | 58.1 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 21.35 Million EUR | -118.81% |
| 2024 Q1 | 26.05 Million EUR | 112.49% |
| 2023 Q1 | 23.8 Million EUR | -37.37% |
| 2023 FY | - EUR | -35.85% |
| 2023 Q4 | 26.9 Million EUR | -77.81% |
| 2023 Q3 | 121.25 Million EUR | 115.36% |
| 2023 Q2 | 56.3 Million EUR | 136.55% |
| 2022 Q2 | 63.4 Million EUR | 95.38% |
| 2022 Q1 | 32.45 Million EUR | 103.45% |
| 2022 FY | - EUR | 69.99% |
| 2022 Q4 | 38 Million EUR | 37.43% |
| 2022 Q3 | 27.65 Million EUR | -56.39% |
| 2021 Q1 | 17.25 Million EUR | 0.0% |
| 2021 Q3 | 15.95 Million EUR | -7.54% |
| 2021 Q2 | 17.25 Million EUR | 0.0% |
| 2021 Q4 | 15.95 Million EUR | 0.0% |
| 2021 FY | - EUR | 58.3% |
| 2020 FY | - EUR | -15.14% |
| 2019 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Affluent Medical SA | -13.34 Million EUR | -1064.656% |
| Bluelinea Société Anonyme | -323.98 EUR | -47965823.514% |
| Carmat SA | -50.45 Million EUR | -208.016% |
| Diagnostic Medical Systems S.A. | -7.05 Million EUR | -2102.069% |
| Euromedis Groupe | -4.43 Million EUR | -3403.797% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 918.498% |
| Ikonisys S.A. | -2.34 Million EUR | -6519.735% |
| Implanet S.A. | -5.07 Million EUR | -2960.863% |
| Median Technologies SA | -19.58 Million EUR | -693.464% |
| SpineGuard SA | -3.49 Million EUR | -4344.038% |
| Theraclion SA | -4.48 Million EUR | -3363.153% |
| Guerbet SA | 98.83 Million EUR | 257.225% |
| Ion Beam Applications SA | 12.53 Million EUR | 1340.223% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 114.928% |
| Sequana Medical NV | -29.13 Million EUR | -433.345% |